Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -57.10% is 44% above its 5-year average of -101.63%, near the high end of its 5-year range (-765.06%–-14.98%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.33% below its 12-month average of -47.46%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -57.10%.
RETURN ON EQUITY (ROE)
-57.10%
RETURN ON EQUITY (ROE) AVG TTM
-47.46%
RETURN ON EQUITY (ROE) AVG 3Y
-49.39%
RETURN ON EQUITY (ROE) AVG 5Y
-101.63%
RETURN ON EQUITY (ROE) AVG 10Y
-141.04%
RETURN ON EQUITY (ROE) AVG 15Y
-131.61%
RETURN ON EQUITY (ROE) AVG 20Y
-167.84%
CURRENT VS TTM AVG
-20.33%
CURRENT VS 3Y AVG
-15.61%
CURRENT VS 5Y AVG
+43.81%
CURRENT VS 10Y AVG
+59.51%
CURRENT VS 15Y AVG
+56.61%
CURRENT VS 20Y AVG
+65.98%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
-35.93%
vs the sector median at left
Tenax Therapeutics, Inc.
Market Cap
$51.19M
Return on Equity (ROE)
-57.10%
TTM Avg
-47.46%
3Y Avg
-49.39%
5Y Avg
-101.63%
Market Cap
$51.23M
Return on Equity (ROE)
-278.89%
TTM Avg
-162.92%
3Y Avg
25.71%
5Y Avg
0.37%
Market Cap
$51.12M
Return on Equity (ROE)
-52.72%
TTM Avg
-32.48%
3Y Avg
-92.81%
5Y Avg
-85.98%
Market Cap
$51.88M
Return on Equity (ROE)
-36.94%
TTM Avg
-31.55%
3Y Avg
-37.51%
5Y Avg
-20.44%
Market Cap
$51.99M
Return on Equity (ROE)
N/A
TTM Avg
31.64%
3Y Avg
119.26%
5Y Avg
-26.51%
Market Cap
$50.28M
Return on Equity (ROE)
N/A
TTM Avg
-24.59%
3Y Avg
-14.57%
5Y Avg
93.61%
Market Cap
$50.27M
Return on Equity (ROE)
-708.48%
TTM Avg
156.13%
3Y Avg
510.26%
5Y Avg
342.91%
Market Cap
$52.60M
Return on Equity (ROE)
-27.93%
TTM Avg
-11.97%
3Y Avg
0.83%
5Y Avg
3.58%
Market Cap
$49.71M
Return on Equity (ROE)
-90.44%
TTM Avg
-163.19%
3Y Avg
-112.62%
5Y Avg
-86.58%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenax Therapeutics, Inc. (TENX) | $51.19M | -57.10% | -47.46% | -49.39% | -101.63% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -278.89% | -162.92% | 25.71% | 0.37% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -52.72% | -32.48% | -92.81% | -85.98% |
| ImageneBio Inc (IMA)vs › | $51.88M | -36.94% | -31.55% | -37.51% | -20.44% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | 31.64% | 119.26% | -26.51% |
| biote Corp. (BTMD)vs › | $50.28M | N/A | -24.59% | -14.57% | 93.61% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -708.48% | 156.13% | 510.26% | 342.91% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -27.93% | -11.97% | 0.83% | 3.58% |
| INmune Bio, Inc. (INMB)vs › | $49.71M | -90.44% | -163.19% | -112.62% | -86.58% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | N/A | 171.70% | 384.85% | 251.73% |
ROE
-57.1%
ROA
-53.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -57.10% |
| 2026-03-31 | -50.49% |
| 2025-12-31 | -54.19% |
| 2025-09-30 | -45.03% |
| 2025-06-30 | -30.47% |
| 2025-03-31 | -22.15% |
| 2024-12-31 | -19.13% |
| 2024-09-30 | -14.98% |
| 2024-06-30 | -141.63% |
| 2024-03-31 | -81.28% |
| 2023-12-31 | -95.22% |
| 2023-09-30 | -62.32% |
| 2023-06-30 | -60.34% |
| 2023-03-31 | -68.17% |
| 2022-12-31 | -740.11% |
| 2022-09-30 | -296.16% |
| 2022-06-30 | -185.62% |
| 2022-03-31 | -712.72% |
| 2021-12-31 | -765.06% |
| 2021-09-30 | -443.36% |
| 2021-03-31 | -999.61% |
| 2020-12-31 | -212.98% |
| 2020-09-30 | -132.55% |
| 2020-06-30 | -324.07% |
| 2020-03-31 | -275.89% |
| 2019-12-31 | -222.51% |
| 2019-09-30 | -119.85% |
| 2019-06-30 | -82.90% |
| 2019-03-31 | -70.14% |
| 2018-12-31 | -58.00% |
| 2018-09-30 | -120.30% |
| 2018-06-30 | -90.46% |
| 2018-03-31 | -84.45% |
| 2017-12-31 | -99.53% |
| 2017-09-30 | -365.43% |
| 2017-06-30 | -356.68% |
| 2017-03-31 | -296.44% |
| 2016-12-31 | -256.25% |
| 2016-09-30 | -40.20% |
| 2015-10-31 | -21.08% |
| 2015-07-31 | -21.69% |
| 2015-04-30 | -17.09% |
| 2015-01-31 | -25.89% |
| 2014-10-31 | -25.77% |
| 2014-07-31 | -23.88% |
| 2014-04-30 | -23.58% |
| 2014-01-31 | -36.26% |
| 2013-10-31 | -352.25% |
| 2013-07-31 | -438.89% |
| 2010-10-31 | -649.50% |
| 2010-07-31 | -305.53% |
| 2010-04-30 | -493.99% |
| 2010-01-31 | -638.26% |
| 2009-10-31 | -455.94% |
| 2009-07-31 | -933.74% |
| 2009-01-31 | -287.05% |
| 2008-10-31 | -143.79% |
| 2008-07-31 | -97.53% |
| 2008-04-30 | -68.92% |
| 2006-01-31 | -650.27% |
| 2005-10-31 | -314.46% |
| 2005-07-31 | -141.60% |
| 2005-04-30 | -281.82% |
| 2005-01-31 | -171.65% |
| 2004-10-31 | -660.59% |
| 2004-07-31 | -248.71% |
| 2004-04-30 | -298.19% |
| 2004-01-31 | -178.88% |
| 2003-10-31 | -153.67% |
| 2003-07-31 | -507.49% |
